Last reviewed · How we verify
NCT06230016: APADHOP
Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program
trial testing questionnaires in Childhood Cancer in 48 participants. Status unknown.
16 August 2025
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 48 |
| Start date | 16 February 2024 |
| Primary completion | 16 August 2025 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- questionnaires
- PedsQL quality of life questionnaires
Conditions studied
- Childhood Cancer — all drugs for Childhood Cancer →
- Adapted Physical Activity — all drugs for Adapted Physical Activity →
Sponsor
University Hospital, Grenoble
Who can join
Adults 3 to 17, any sex, with Childhood Cancer or Adapted Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse. The aim of this study is to keep the children in the APA programm during all the treatment lenght. This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm. The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06230016
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of questionnaires
Trials testing the same drug.
- NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
- NCT07508553 — Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Question · NA · recruiting
- NCT05969457 — Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES App · Phase 3 · not yet recruiting
- NCT06399562 — Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province · completed
- NCT06317714 — Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs · recruiting
Other recruiting trials for Childhood Cancer
Currently open trials in the same condition.
- NCT06839794 — Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients · NA · recruiting
- NCT06609473 — Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Surviv · NA · recruiting
- NCT06854822 — Siblings to a Child with Cancer: Needs and Pre-loss Grief · recruiting
- NCT06769334 — Preparing for Life and Academics for Young Childhood Cancer Survivors · NA · recruiting
- NCT06053268 — Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors · NA · active not recruiting
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06230016 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06230016.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing